Finally, we demonstrated that EA functions by inhibiting the recruitment of LEF1 to DNA promoters and restoring cylindromatosis (CYLD) expression in CLL cells. This evidence concerns the gene LEF1 and B-cell chronic lymphocytic leukemia.